Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage: A critically appraised topic

Katherine C. Riordan, Dean Marko Wingerchuk, Kay E. Wellik, Richard S. Zimmerman, Joseph I. Sirven, Katherine H. Noe, Bhavesh M. Patel, Bart M Demaerschalk

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Seizures are a complication of aneurysmal subarachnoid hemorrhage (aSAH). Objective: To evaluate whether antiepileptic drug (AED) prophylaxis after aSAH reduces seizure risk and whether it is associated with improved neurological outcomes. Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom line conclusions. Neurology consultants and residents, a medical librarian, clinical epidemiologists, and content experts in the fields of epilepsy, neurosurgery, and critical care contributed to the review and placed the evidence in clinical context. Results: There were no relevant randomized, controlled trials that addressed the question. A post hoc analysis of data from 4 trials of tirilazad for aSAH showed that prophylactic AED therapy was associated with worse Glasgow Outcome Scale scores at 3 months (odds ratio 1.56, 95% confidence interval 1.16-2.10; P = 0.003) but numerous confounders limit data interpretation. Conclusions: There are insufficient data to support or refute the prophylactic use of AED therapy after aSAH. Randomized, controlled trials are needed to address the efficacy and risks of AEDs in this setting and should take into account factors such as aneurysmal factors (location, hemorrhage grade, degree of parenchymal injury), type of aneurysm surgery (clip vs. coil), and evaluate the timing and duration of AED use.

Original languageEnglish (US)
Pages (from-to)397-399
Number of pages3
JournalNeurologist
Volume16
Issue number6
DOIs
StatePublished - Nov 2010
Externally publishedYes

Fingerprint

Subarachnoid Hemorrhage
Anticonvulsants
Drug Therapy
Seizures
Randomized Controlled Trials
Librarians
Glasgow Outcome Scale
Neurosurgery
Critical Care
Neurology
Consultants
Surgical Instruments
Aneurysm
Epilepsy
Odds Ratio
Confidence Intervals
Hemorrhage
Wounds and Injuries

Keywords

  • Aneurysm
  • anticonvulsants
  • comparative effectiveness
  • critically appraised topic
  • evidence-based medicine
  • prevention
  • seizures
  • subarachnoid hemorrhage

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage : A critically appraised topic. / Riordan, Katherine C.; Wingerchuk, Dean Marko; Wellik, Kay E.; Zimmerman, Richard S.; Sirven, Joseph I.; Noe, Katherine H.; Patel, Bhavesh M.; Demaerschalk, Bart M.

In: Neurologist, Vol. 16, No. 6, 11.2010, p. 397-399.

Research output: Contribution to journalArticle

Riordan, Katherine C. ; Wingerchuk, Dean Marko ; Wellik, Kay E. ; Zimmerman, Richard S. ; Sirven, Joseph I. ; Noe, Katherine H. ; Patel, Bhavesh M. ; Demaerschalk, Bart M. / Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage : A critically appraised topic. In: Neurologist. 2010 ; Vol. 16, No. 6. pp. 397-399.
@article{026e575215044e5fafd015495aa3eb19,
title = "Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage: A critically appraised topic",
abstract = "Background: Seizures are a complication of aneurysmal subarachnoid hemorrhage (aSAH). Objective: To evaluate whether antiepileptic drug (AED) prophylaxis after aSAH reduces seizure risk and whether it is associated with improved neurological outcomes. Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom line conclusions. Neurology consultants and residents, a medical librarian, clinical epidemiologists, and content experts in the fields of epilepsy, neurosurgery, and critical care contributed to the review and placed the evidence in clinical context. Results: There were no relevant randomized, controlled trials that addressed the question. A post hoc analysis of data from 4 trials of tirilazad for aSAH showed that prophylactic AED therapy was associated with worse Glasgow Outcome Scale scores at 3 months (odds ratio 1.56, 95{\%} confidence interval 1.16-2.10; P = 0.003) but numerous confounders limit data interpretation. Conclusions: There are insufficient data to support or refute the prophylactic use of AED therapy after aSAH. Randomized, controlled trials are needed to address the efficacy and risks of AEDs in this setting and should take into account factors such as aneurysmal factors (location, hemorrhage grade, degree of parenchymal injury), type of aneurysm surgery (clip vs. coil), and evaluate the timing and duration of AED use.",
keywords = "Aneurysm, anticonvulsants, comparative effectiveness, critically appraised topic, evidence-based medicine, prevention, seizures, subarachnoid hemorrhage",
author = "Riordan, {Katherine C.} and Wingerchuk, {Dean Marko} and Wellik, {Kay E.} and Zimmerman, {Richard S.} and Sirven, {Joseph I.} and Noe, {Katherine H.} and Patel, {Bhavesh M.} and Demaerschalk, {Bart M}",
year = "2010",
month = "11",
doi = "10.1097/NRL.0b013e3181efc92f",
language = "English (US)",
volume = "16",
pages = "397--399",
journal = "Neurologist",
issn = "1074-7931",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage

T2 - A critically appraised topic

AU - Riordan, Katherine C.

AU - Wingerchuk, Dean Marko

AU - Wellik, Kay E.

AU - Zimmerman, Richard S.

AU - Sirven, Joseph I.

AU - Noe, Katherine H.

AU - Patel, Bhavesh M.

AU - Demaerschalk, Bart M

PY - 2010/11

Y1 - 2010/11

N2 - Background: Seizures are a complication of aneurysmal subarachnoid hemorrhage (aSAH). Objective: To evaluate whether antiepileptic drug (AED) prophylaxis after aSAH reduces seizure risk and whether it is associated with improved neurological outcomes. Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom line conclusions. Neurology consultants and residents, a medical librarian, clinical epidemiologists, and content experts in the fields of epilepsy, neurosurgery, and critical care contributed to the review and placed the evidence in clinical context. Results: There were no relevant randomized, controlled trials that addressed the question. A post hoc analysis of data from 4 trials of tirilazad for aSAH showed that prophylactic AED therapy was associated with worse Glasgow Outcome Scale scores at 3 months (odds ratio 1.56, 95% confidence interval 1.16-2.10; P = 0.003) but numerous confounders limit data interpretation. Conclusions: There are insufficient data to support or refute the prophylactic use of AED therapy after aSAH. Randomized, controlled trials are needed to address the efficacy and risks of AEDs in this setting and should take into account factors such as aneurysmal factors (location, hemorrhage grade, degree of parenchymal injury), type of aneurysm surgery (clip vs. coil), and evaluate the timing and duration of AED use.

AB - Background: Seizures are a complication of aneurysmal subarachnoid hemorrhage (aSAH). Objective: To evaluate whether antiepileptic drug (AED) prophylaxis after aSAH reduces seizure risk and whether it is associated with improved neurological outcomes. Methods: The objective was addressed through the development of a critically appraised topic that included a clinical scenario, structured question, search strategy, critical appraisal, assessment of results, evidence summary, commentary, and bottom line conclusions. Neurology consultants and residents, a medical librarian, clinical epidemiologists, and content experts in the fields of epilepsy, neurosurgery, and critical care contributed to the review and placed the evidence in clinical context. Results: There were no relevant randomized, controlled trials that addressed the question. A post hoc analysis of data from 4 trials of tirilazad for aSAH showed that prophylactic AED therapy was associated with worse Glasgow Outcome Scale scores at 3 months (odds ratio 1.56, 95% confidence interval 1.16-2.10; P = 0.003) but numerous confounders limit data interpretation. Conclusions: There are insufficient data to support or refute the prophylactic use of AED therapy after aSAH. Randomized, controlled trials are needed to address the efficacy and risks of AEDs in this setting and should take into account factors such as aneurysmal factors (location, hemorrhage grade, degree of parenchymal injury), type of aneurysm surgery (clip vs. coil), and evaluate the timing and duration of AED use.

KW - Aneurysm

KW - anticonvulsants

KW - comparative effectiveness

KW - critically appraised topic

KW - evidence-based medicine

KW - prevention

KW - seizures

KW - subarachnoid hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=78650805870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650805870&partnerID=8YFLogxK

U2 - 10.1097/NRL.0b013e3181efc92f

DO - 10.1097/NRL.0b013e3181efc92f

M3 - Article

C2 - 21150393

AN - SCOPUS:78650805870

VL - 16

SP - 397

EP - 399

JO - Neurologist

JF - Neurologist

SN - 1074-7931

IS - 6

ER -